Completed KT-621 (STAT6) SAD/MAD Phase 1 healthy volunteer trial with data to be reported in June 2025 First patient dosed...
announces
1Q 2025 Total Revenue of $114.8 Million (Adjusted Total Revenue(1) of $118.6 Million), a 40% YoY Increase 1Q 2025 GAAP...
New York, New York, May 05, 2025 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC,...
Listen to this article Sales of commercial properties in Jonestown and Harrisburg have been announced by Landmark Commercial Realty. Headquartered...
WOONSOCKET, R.I., April 8, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced two leadership updates. Brian Newman has been...
New York, New York, March 24, 2025 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC,...
